VEGFA and neoplasm: Many studies showed that the use of anti-VEGF-targeted drugs can promote the normalization of tumor vasculature that can increase the infiltration of immune effector cells into tumors and convert the intrinsically immunosuppressive TME to become immunostimulatory.30 Thus, combining antiangiogenic therapies and immunotherapies might synergistically increase the effectiveness of immunotherapy.